| Brand Name | Glatt Pharmaceuticals |
|---|---|
| Industry / Business Category | Pharmacies (Pharmaceutical Manufacturing & Distribution) |
| Founded Year | 2018 |
| Franchise Started Year | 2024 |
| Total Franchise Outlets | 1 – 10 |
| Estimated Investment | INR 10,000 – 50,000 |
| Franchise Fee | Typically covers brand licensing and onboarding support |
| Royalty Fee | Typically applies for brand usage and operational support |
| Space Requirement | 100 – 200 sq. ft. |
| Staff Requirement | Pharmacy staff and sales personnel |
| Expected Payback Period | 1 – 2 years |
Glatt Pharmaceuticals is a pharmaceutical company operating in the healthcare and pharmacy sector, focused on manufacturing and supplying medicines including generic drugs, over-the-counter products, and specialty formulations. The franchise operates within the pharmacy and pharmaceutical distribution category, serving healthcare providers and end consumers.
The Glatt Pharmaceuticals franchise represents a distribution-led model connecting manufacturing capabilities with retail or institutional demand.
The business combines pharmaceutical supply with retail or distribution activities.
Revenue is generated through the sale of pharmaceutical products and related healthcare items.
The franchise focuses on pharmaceutical and healthcare product distribution.
Cost-effective pharmaceutical formulations
Non-prescription healthcare items
Targeted treatments for specific conditions
Products used in clinical and home care settings
The offering is aligned with both prescription-driven and consumer healthcare demand.
The franchise model is structured around distribution and retail of pharmaceutical products.
This structure ensures consistency in product availability and compliance standards.
The investment is designed for a small-format pharmaceutical outlet.
| Estimated Investment | INR 10,000 – 50,000 |
|---|---|
| Franchise Fee | Covers brand usage and onboarding |
| Royalty | May apply as a percentage of sales or fixed fee |
In pharmacy franchises, a portion of the investment typically goes toward inventory and regulatory compliance.
The business operates in a compact retail or distribution format.
| Space | 100 – 200 sq. ft. |
|---|---|
| Location Type | Residential clusters, near clinics, or commercial areas |
| Infrastructure Needs | — |
Support systems focus on compliance, product knowledge, and operations.
These systems help franchise partners manage a regulated business environment effectively.
Revenue is generated through the sale of medicines and healthcare products.
Margins depend on product mix, supplier pricing, and customer base.
The brand’s growth aligns with increasing demand for pharmaceutical distribution networks.
This opportunity may suit:
The investment typically ranges from INR 10,000 to 50,000, depending on inventory and setup requirements. Additional costs may include licensing, storage infrastructure, and initial stock procurement for the pharmacy.
The business operates as a pharmacy or distribution outlet where medicines are sold to customers and healthcare providers. Revenue is generated through product sales, with operations focused on inventory management and regulatory compliance.
A compact space of around 100 to 200 square feet is sufficient. The location should be accessible to customers, ideally near residential areas, clinics, or healthcare centers.
The expected payback period is approximately 1 to 2 years. Recovery depends on product demand, customer base, and operational efficiency.
Investors can apply by contacting the brand directly or through franchise platforms. The process generally involves evaluation, onboarding, and setup support for launching the outlet.
Entrepreneurs evaluating pharmacy and healthcare franchises may also consider:
These brands operate within the pharmaceutical retail and distribution ecosystem, offering comparable business formats for investor evaluation.
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.